Additional Inhibition of Wnt/β-Catenin Signaling by Metformin in DAA Treatments as a Novel Therapeutic Strategy for HCV-Infected Patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Additional Inhibition of Wnt/β-Catenin Signaling by Metformin in DAA Treatments as a Novel Therapeutic Strategy for HCV-Infected Patients
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 4, Pages 790
Publisher
MDPI AG
Online
2021-04-02
DOI
10.3390/cells10040790
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis
- (2020) Jiaxin Zhang et al. PLoS One
- Metformin‑activated AMPK regulates β‑catenin to reduce cell proliferation in colon carcinoma RKO cells
- (2019) Song Park et al. Oncology Letters
- The current state and future directions of RNAi-based therapeutics
- (2019) Ryan L. Setten et al. NATURE REVIEWS DRUG DISCOVERY
- Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents
- (2019) Winnie Y. Zou et al. DIGESTIVE DISEASES AND SCIENCES
- Promotion of growth factor signaling as a critical function of β-catenin during HCC progression
- (2019) Eunsun Kim et al. Nature Communications
- The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances
- (2019) Pouya Saraei et al. Cancer Management and Research
- Long-term risk of hepatocellular carcinoma in HCV patients treated with direct acting antiviral agents
- (2019) Fasiha Kanwal et al. HEPATOLOGY
- Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review
- (2019) Victor Cunha et al. Annals of Hepatology
- Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs
- (2018) Pierre Nahon et al. GASTROENTEROLOGY
- Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes
- (2018) Chin-Hsiao Tseng LIVER INTERNATIONAL
- Cancer cell specific inhibition of Wnt/β-catenin signaling by forced intracellular acidification
- (2018) Svitlana Melnik et al. Cell Discovery
- Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study
- (2017) Philippe Kolly et al. JOURNAL OF HEPATOLOGY
- Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C
- (2017) Hiroko Nagata et al. JOURNAL OF HEPATOLOGY
- The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience
- (2017) R. Bielen et al. JOURNAL OF VIRAL HEPATITIS
- Chaperone-mediated autophagy compensates for impaired macroautophagy in the cirrhotic liver to promote hepatocellular carcinoma
- (2017) Srinivas Chava et al. Oncotarget
- Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
- (2016) Fabio Conti et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: First, do no harm by withdrawing treatment
- (2016) Harrys A. Torres et al. JOURNAL OF HEPATOLOGY
- High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis
- (2016) Helder Cardoso et al. JOURNAL OF HEPATOLOGY
- Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment
- (2016) Karin Kozbial et al. JOURNAL OF HEPATOLOGY
- Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
- (2016) María Reig et al. JOURNAL OF HEPATOLOGY
- Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial
- (2016) Takuma Higurashi et al. LANCET ONCOLOGY
- Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
- (2015) Eleonore Beurel et al. PHARMACOLOGY & THERAPEUTICS
- Differential AMPK phosphorylation by glucagon and metformin regulates insulin signaling in human hepatic cells
- (2014) Darius Kang Lie Aw et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- AMP-Activated Protein Kinase Suppresses the In Vitro and In Vivo Proliferation of Hepatocellular Carcinoma
- (2014) Jidong Cheng et al. PLoS One
- Promoter hypermethylation of Wnt pathway inhibitors in hepatitis C virus - induced multistep hepatocarcinogenesis
- (2014) Muhammad Umer et al. Virology Journal
- HCV Infection Selectively Impairs Type I but Not Type III IFN Signaling
- (2013) Partha K. Chandra et al. AMERICAN JOURNAL OF PATHOLOGY
- NS5A inhibitor, daclatasvir, for the treatment of chronic hepatitis C virus infection
- (2013) D Alan Herbst et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial–mesenchymal transition
- (2013) H Quan et al. ONCOGENE
- MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway
- (2012) I-Shan Hsieh et al. CARCINOGENESIS
- HCV NS5A Inhibitors in Development
- (2012) Anna Suk-Fong Lok Clinics in Liver Disease
- Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer
- (2012) Robin M. Hallett et al. PLoS One
- Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow
- (2011) Tarik Asselah et al. LIVER INTERNATIONAL
- Metformin and cancer: new applications for an old drug
- (2011) Taxiarchis V. Kourelis et al. MEDICAL ONCOLOGY
- Enhancement of Canonical Wnt/β-Catenin Signaling Activity by HCV Core Protein Promotes Cell Growth of Hepatocellular Carcinoma Cells
- (2011) Jiao Liu et al. PLoS One
- Hypermethylated levels of E-cadherin promoter in Huh-7 cells expressing the HCV core protein
- (2011) Maria Ripoli et al. VIRUS RESEARCH
- Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma
- (2011) Junfang Ji et al. Cell and Bioscience
- Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial
- (2010) K. Hosono et al. Cancer Prevention Research
- Epigenetic disruption of the WNT/ß-catenin signaling pathway in human cancers
- (2010) Ying Ying et al. Epigenetics
- Axin downregulates TCF-4 transcription via β-catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells
- (2010) Lian-He Yang et al. Molecular Cancer
- Nonstructural 5A protein activates β-catenin signaling cascades: Implication of hepatitis C virus-induced liver pathogenesis
- (2009) Chul-Yong Park et al. JOURNAL OF HEPATOLOGY
- Epigenetic side-effects of common pharmaceuticals: A potential new field in medicine and pharmacology
- (2009) Antonei B. Csoka et al. MEDICAL HYPOTHESES
- Activated Wnt/ss-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model
- (2009) A. J. Chien et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now